Journal Section:
Editorial
Keywords:
ONKOPEDIA, Guidelines

The development of guidelines is of great importance for ensuring modern, quality-assured, and standardized treatment in all areas of medicine. Many studies have used outcome data to describe how access to guideline-concordant therapy improves the prognosis of tumor patients, e.g., [1‒3]. Not least for this reason, it is important to have up-to-date and readily available guidelines at hand, especially for areas of medicine with a very dynamic development of treatment options (whether these are drug-based or multimodal therapy). This also applies in particular to developments in modern oncology.

The ONKOPEDIA guidelines are a joint project of German, Swiss and Austrian specialist societies (OeGHO, SGMO, and SGH+SSH in addition to the DGHO) under the leadership of the German Society for Hematology and Oncology (DGHO). ONKOPEDIA was established in 2010 as a portal for the creation and publication of guidelines, the content of which is presented in a condensed, clear, up-to-date, and freely accessible format (www.onkopedia.com). The guidelines are, meanwhile, available in both German and English. The homepage is currently visited by an average of around 50,000 different visitors per month.

We are therefore very pleased that in future we will be able to make practice-relevant innovations “in a nutshell” from current ONKOPEDIA guidelines available to the readers of Oncology Research and Treatment in the series “ONKOPEDIA: What’s New” in loose order and in cooperation with the DGHO. In this issue, we are starting with locally advanced rectal cancer [4], certainly one of the solid tumors for which there have been fewer changes in drug therapy than in multimodal treatment and therapy concepts. We are pleased to be able to contribute to the further dissemination of these guidelines and thereby to the optimization of treatment for our patients.

The authors have no conflicts of interest to declare.

No funding was received.

Both authors, Ralf-Dieter Hofheinz and Sylvie Lorenzen, wrote and approved this editorial.

1.
Javid
SH
,
Varghese
TK
,
Morris
AM
,
Porter
MP
,
He
H
,
Buchwald
D
, et al.
Guideline-concordant cancer care and survival among American Indian/Alaskan Native patients
.
Cancer
.
2014
;
120
(
14
):
2183
–
90
.
Google Scholar
Crossref
Search ADS
PubMed
 
2.
Chan
K
,
Palis
BE
,
Cotler
JH
,
Janczewski
LM
,
Weigel
RJ
,
Ko
CY
, et al.
Social vulnerability and receipt of guideline-concordant care among patients with colorectal cancer
.
J Am Coll Surg
.
2024
. Online ahead of print.
Google Scholar
 
3.
Tissera
S
,
Billah
B
,
Brand
M
,
Karim
MN
,
Antippa
P
,
Blum
R
, et al.
Stage-specific guideline concordant treatment impacts on survival in nonsmall cell lung cancer: a novel quality indicator
.
Clin Lung Cancer
.
2024
. Online ahead of print.
Google Scholar
 
4.
Hofheinz
R-D
,
Arnold
D
,
Borner
M
, et al.
Guidelines: onkopedia: what’s new? Locally advanced rectal cancer
.
Oncol Res Treat
.
2024
;
17
:
1
–
9
.
Google Scholar
 
© 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024